Malaria Treatment Articles & Analysis
7 news found
“Ready access to this life-saving drug is such an important tool in the global fight against malaria. The additional funding we have received will enable us to translate a robust technology built with our BioAssemblyLineTM cell factory engineering platform into a fully scaled process.” A key time to beat malaria… Malaria ...
Additionally, in 2020, the foundation awarded a $4.2 million grant to Exscientia to identify new innovative treatments for malaria and tuberculosis – two of the world’s leading infectious disease killers – as well as new medicines for non-hormonal contraception. ...
Artesunate for Injection 110 mg, powder and solvent for solution is launching in the U.S. for initial treatment of severe malaria in adult and pediatric patients. From 2007 until today, the product was available in the U.S. only through an expanded access investigational new drug (IND) program managed by the Centers for Disease Control and Prevention (CDC). ...
Artesunate for Injection 110 mg, powder and solvent for solution is approved by FDA for initial treatment of severe malaria in adult and pediatric patients. Artesunate for Injection is in a group of drugs known as “artemisinin derivatives” and is on the World Health Organization Model List of Essential Medicines. ...
The World Malaria Day theme from 2013 – 2015 is ‘Invest in the future, defeat malaria’. ...
Wellems, M.D., Ph.D., chief of the laboratory of malaria and vector research at the National Institute of Allergy and Infectious Diseases; and Carl Wu, Ph.D., chief of the laboratory of biochemistry and molecular biology, Center for Cancer Research at the National Cancer Institute. ...
Currently, only two drugs are approved for treatment: benznidazole and nifurtimox. "While significant progress has been made in recent years in the prevention of the transmission of this potentially life-threatening disease, no new drugs have been approved for the treatment of chronic Chagas disease in over three decades," said Roger J. ...